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ALTERED NUCLEAR TRANSFER: SCIENTIFIC,
LEGAL, AND ETHICAL FOUNDATIONS*
William B. Hurlbut, MD.
Throughout the 20th century, the great advances in molecular and cell
biology were accomplished largely through the study of limited biochemical
processes apart from their natural place within the whole organism. By
breaking down organic systems into their component parts and looking at
living beings in terms of inanimate matter, we opened an era of scientific
discovery that has culminated in the sequencing of the human genome.
Now, however, as we move from genomics to proteomics and on to the
investigation of developmental biology, we are returning to the study of
whole living beings. When applied to human biology, this inquiry reopens
the most fundamental questions concerning the very definition of life and the
adequacy of our current scientific approach to inform discussion of the
ethical and legal dilemmas raised by our new perspectives and powers.
These questions have been forced to the foreground of public awareness
by our deepening controversy over embryonic stem cell (ESC) research, and
more specifically by proposals for the production of cloned human embryos
as a source of these cells. This conflict is sometimes framed as a battle
between the subjectivity of personal religious belief and the objectivity of
science, but it is far more fundamental than that. Distilled in this difficult
debate are the most profound considerations concerning the relationship
between the material, physio-chemical mechanisms and the moral meaning
of human life.
A careful consideration of the foundations of this controversy can place it
within a broader social and scientific context and bring into focus the crucial
concerns that underlie our present political impasse. Drawing on this debate,
particularly as it developed within the President's Council on Bioethics (on
which I serve), we can discuss the immediate ethical issues in ESC research.
* This essay is based on Dr. Hurlbut's remarks given on October 4, 2004 at the
colloquium on Ethics, Public Policy and Law: The Stem Cell Debate in the United States
and the Federal Republic of Germany sponsored by The Law, Philosophy & Culture
Initiative of The Catholic University of America's Columbus School of Law with The
Konrad Adenaur Foundation. A separate version of this essay subsequently appeared as
Framing the Future: Embryonic Stem Cells, Ethics and the Emerging Era of
Developmental Biology, 59 PEDIATRIC REs. 4R (2006). The Journal of Contemporary
Health Law and Policy kindly thanks Pediatric Research for the inclusion of this essay.
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At the same time, we can seek a wider understanding that may set the frame
for scientific and medical advance in the era of developmental biology. It is
clear that ESC research is just the first of many dilemmas that will challenge
our traditional understanding of human life. Parthenogenesis, human-animal
chimeras, human body parts grown in laboratories-these and a wide range
of other emerging technologies make it imperative that we define the
boundaries of humanity with clarity and precision in order to preserve the
essential unity of the human person.
Through such a reflection on the meaning of human embodiment, we may
draw a distinction between the material parts and the living whole that
defines the locus of our moral concern. This distinction may suggest a way
forward that will allow positive progress in biomedical science while
preserving our most fundamental principles for the protection of human
subjects and the defense of human dignity.
SOCIAL AND POLITICAL FOUNDATIONS
On August 9, 2001, President Bush, in his first major policy address to the
nation, discussed what he described as "a complex and difficult issue, an
issue that is one of the most profound of our time," the scientific and moral
considerations in stem cell research.' He described the wide consultation
and deep reflection that had gone into his consideration of the important yet
competing goods at stake. And he announced that after several months of
difficult deliberation he had decided that federal funds would be made
available to support research with certain already extant ESC lines, but
would not support research that would encourage any further destruction of
human embryos. Some regarded this decision as a cynical political
compromise while others saw it as a courageous acknowledgement of the
important values on both sides on this difficult debate. Few, however,
seemed to have understood either the historical foundations or the legal
constraints within which this policy decision was made.
The issue of research on embryos and fetuses has been the subject of
controversy and conflict for more than thirty years. With the advent of in
vitro fertilization (IVF) in the late 1970s, the laboratory production of large
numbers of human embryos became possible, and, with them, opportunities
to study fertilization and early embryonic development. At the same time,
strong objections were raised that taxpayers' dollars not be put toward
1. President George W. Bush, Address to the Nation on Stem Cell Research from
Bush Ranch, Crawford, Texas (Aug. 9, 2001), available at http://www.whitehouse.gov/
news/releases/2001/08/20010809-2.html (last visited Sept. 1, 2006).
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specific sorts of research that violates the moral convictions and sensibilities
of a large portion of the American public.
Over the next decade and a half, a series of national commissions and
advisory boards made various recommendations, but funding was effectively
blocked; first by a congressional moratorium, and then by a de facto ban by
the Department of Health and Human Services (HHS). In 1994, the National
Institutes of Health (NIH) convened the Human Embryo Research Panel that
made two recommendations. First, they recommended federal funding for
some forms of research using embryos left over from IVF procedures. And
second, they concluded that, in some circumstances, federal funds should
support the direct creation of human embryos with the explicit intention of
using them for research purposes.
President Clinton overruled the panel on the latter point, but he did accept
the panel's first recommendation and permit the NIH to consider
applications for funding of research using embryos left over from IVF
procedures. Congress, however, did not endorse this course of action.
Toward the end of 1995, before any funding proposals had been approved by
the NIH, Congress attached language to the 1996 Departments of Labor,
Health and Human Services, and Education, and Related Agencies
Appropriations Act (the annual budget bill that funds HHS and the NIH)
prohibiting the use of federal funds for any research that destroys, discards,
or seriously endangers human embryos, or that creates them for research
purposes. This provision, known as the "Dickey Amendment, ' 2 has been
attached to the HHS appropriations bill each year since 1996. Everything
about the subsequent debate must be understood in the context of these legal
restrictions.
The Dickey Amendment effectively prohibits the use of federal funds to
support any research that endangers or destroys human embryos; it does not
prohibit the conduct of such research using private funding. The amendment
expresses the ethical conviction, as represented in the United States
Congress, that nascent human life should be protected, not instrumentally
used in scientific research, however promising that research may be. And,
while not proscribing such research, it affirms that, at the very least, the
destruction of human embryos should not be supported or encouraged by
taxpayer dollars.
The first year after the Dickey Amendment took effect the cloning of
Dolly was announced, and just two years later the isolation of human ESCs
from IVF embryos was accomplished. These developments, with their
promise of new avenues of progress in science and medicine, caused great
excitement within and beyond the scientific community. There were new
calls for federal funding of embryo research and specifically for the creation
2. See, e.g., Pub. L. No. 104-99, § 128, 110 Stat. 26.
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of tissue compatible sources of ESCs by "therapeutic cloning." Most
Members of Congress, however, did not change their position, and the
Dickey Amendment has been reenacted by a large majority every year
since-most recently with a provision prohibiting federal funding for the
creation of cloned embryos.
This seemed to close the question of the use of federal funds for human
ESC research, but in 1999 the General Counsel of the HHS argued that the
wording of the law might permit the use of federal funds for the study of
ESCs lines if the actual destruction of the embryos from which they were
obtained was done off site and with private funds. Critics objected that such
an interpretation was a technical loophole, consistent only with the letter but
not the spirit of the law. President Clinton, however, accepted this approach
and ordered that guidelines be drawn up for its implementation. But these
guidelines were completed just before the end of the Clinton administration
and were never put into practice.
When President Bush took office, in January 2001, these new regulations
were put on hold pending review and the search for a way forward that
would uphold the spirit (and not just the letter) of the Dickey amendment.
The hope was expressed that, while continuing to withhold taxpayer support
for the destruction of human embryos, some moral good might be drawn
from the existing stem cell lines, given that the destructive acts that
produced these lines could not now be undone. It was with this combination
of concerns and intentions (and within the constraints of existing law) that,
on August 9, 2001, the President announced the approval of federal funding
of research using ESC lines created before the date of his announcement,
estimated to be in the range of 60-70 lines. At the same time,
acknowledging the serious ethical dilemmas across a range of issues raised
by rapid advances in biotechnology, the President announced the
establishment of the President's Council on Bioethics.
THE PRESIDENT'S COUNCIL DELIBERATIONS ON CLONING
President Bush set the following mandate for this Council: first, to
monitor stem cell research and to recommend appropriate guidelines; then to
consider more broadly the medical and ethical ramification of biomedical
innovation. Further, he asked that the Council help serve as the conscience
of the country, to engage and educate the public and to advise him and the
nation by articulating the strongest arguments on all sides of these difficult
issues. Our initial assignment was to address the controversy over human
cloning, including its implications for stem cell research.3
3. In the account that follows I speak from the perspective of my own experience
and not for the Council as a whole.
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In reflecting on these dilemmas, it was immediately clear that we were at
a defining moment in the progress of science. The choices our society makes
now regarding ESCs (and other ethically controversial uses of biomedical
technology) will put into place both the conceptual principles and practical
foundations for future techniques of research and patterns of clinical
practice. Once established, these moral precedents and scientific techniques
will serve as the platform on which further practice will be built layer upon
layer; like the foundations of a building, these will be difficult to retract or
revise. There was an earnest intensity and sense of seriousness to the
Council's discussion of these matters; we recognized that the issues were of
broad significance for our civilization and, indeed, the future of our species.
Therefore, the foundations we set had to transcend pre-established cultural
preferences and partisan political agendas; they had to establish the basis for
social consensus and global cooperation. We understood that without clear
and distinct ethical principles, grounded in scientific evidence and reasoned
moral argument, no policy could be effectively formulated or enforced.
The Council's discussion of the ethical issues centered around two poles,
with the scientific and medical promise on the one hand, and the prudential
and moral concerns on the other. Through a wide range of expert testimony
and public comment, a compelling case was made for the importance of
stem cell biology and its potential significance in medical application. The
convergence of technologies following from advances in genomics,
cytology, and developmental biology were delivering unprecedented powers
for scientific research and intervention at the most basic levels of human
biology. The fundamental questions of human embryology were opening up:
studies of cell signaling, imprinting and differentiation, the positional cues
that establish the body axes, body plan, and patterns of organogenesis. An
understanding of these basic biological processes, together with a resource
of ESCs from a full range of genotypes reflecting both normal and
pathological potentials, would provide extraordinary tools for the modeling
of disease, studies of toxicology and testing of pharmaceuticals. An
estimated 150,000 babies are born every year in the US with congenital
defects, and evidence suggests that a range of later pathologies have their
foundations in early development. Furthermore, basic developmental
processes, and their disordered dynamics, seem to be at work in a number of
adult pathologies including some forms of cancer. Notwithstanding the
obvious hyperbole in the political promotion of ESC research-"128 million
Americans with incurable diseases might benefit"-it seemed clear that we
truly were entering a new era of uncharted opportunity for scientific and
medical advance. The age of regenerative medicine, cell therapies, tissue
rejuvenation, and custom organ replacement seemed conceptually real even
if not within immediate reach. Far more than just ESC science was at stake;
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hanging in the balance were the wider scientific and medical prospects of
this whole emerging era of discovery.
We recognized, however, that the same technological powers that offer
such positive possibilities might also radically revise the traditional conduct
of scientific research and its application in clinical medicine. Of central
concern was the "embryo issue." All of the other considerations, including
the troubling issues related to the use of human eggs for projects of nuclear
transfer, seemed to be more matters of prudent regulation than
disagreements over fundamental principle. But with regard to the moral
standing of the embryo, it was apparent that deep differences in basic
assumptions were precluding social consensus. Yet it was not simply
personal beliefs or different cultural traditions, nor was it lack of scientific
understanding that was causing the divide. It seemed clear that, within the
current frame of discussion, we lacked conceptual tools and terms of
understanding adequate to bring resolution. It was as though the conceptual
revolution that had opened such extraordinary avenues of advance in basic
biology had now delivered dilemmas which its analytic and reductive
assumptions and methodologies were inadequate to address.
To resolve the conflict concerning the human embryo, we needed to find a
framework to explore the most fundamental questions conceming the very
source of our moral standing and the ways human life is morally different
from the other life forms that we use respectfully but instrumentally for
human good. We had to ponder what potential capabilities and
manifestations of form or function, endow a developing life with human
value and inviolability. Similarly, we had to ask what lack of these qualities
or capacities rightly reduces biological material to mere matter and
information, available for instrumental use in projects of medical science.
Ultimately, we recognized that more time was needed for a thorough and
thoughtful consideration of the moral status of the human embryo. The
Council as a group acknowledged that this was not simply an issue of
balancing competing goods, but that fundamental principles were at stake
that would not be amenable to compromise or negotiated resolution. After
extended deliberation, a majority of the Council felt that the wisest course of
action for our nation was a four-year moratorium on cloning for biomedical
research ("CBR"). Several members of the Council added personal
statements to an appendix of this report. In my own comments, I expressed
the hope that the period of the moratorium might be used to seek a scientific
solution to our national impasse and described one possible technological
approach to which I gave the name "Altered Nuclear Transfer" ("ANT").
The Council's recommendations concerning cloning were never
implemented as specific legislation, but the constraints of the Dickey
Amendment and the guidelines of the President's executive order against
Spring 2006]
Journal of Contemporary Health Law and Policy [Vol. XXII:458
embryo destruction effectively precluded federal funding both of research
cloning and the production of new ESC lines from IVF embryos. Eighteen
months after our report on cloning, the Council issued a broader analysis of
the social, legal and scientific dimensions of stem cell research entitled
"Monitoring Stem Cell Research." This report included a short discussion
of scientific proposals to obtain embryonic stem cells by means that do not
require the destruction of human embryos. A year later, in May 2005, we
returned to this topic and issued a White Paper entitled, "Alternative Sources
of Human Pluripotent Stem Cells." Our report outlined a range of proposals
that might allow the procurement of pluripotent stem cells (cells with the
same functional properties as embryonic stem cells), without the destruction
of human embryos. Among the proposals discussed and recommended for
preliminary exploration in animal models were two approaches that would
allow the production of patient-specific pluripotent stem cell lines of any
genetic type: direct reprogramming and ANT. In what follows I will draw
on the moral and scientific foundations of the ANT proposal to discuss how
our nation may open a way forward for stem cell research and, at the same
time, set guiding principles that will allow ongoing advance as we enter the
era of developmental biology.
THE MORAL MEANING OF EMERGING LIFE
Assessing the moral status of the embryo begins with affirming the moral
status of human life in general.4 The principle that human life constitutes
the fundamental good serves as the cornerstone of law for our civilization. In
no circumstance is the intentional destruction of the life of an innocent
individual deemed morally acceptable. This valuing of human life is indeed
the moral starting point for both advocates and opponents of CBR, and it
flows from the reciprocal respect that we naturally grant as we recognize in
the other a being of moral equivalence to ourselves. It leads to the principle
of inviolability of human life and the prohibition against using human life
instrumentally.
From the perspective of those who object to research that involves the
destruction of embryos, an evaluation of the moral significance of human
life must take into account the full procession of continuity and change that
is essential for its development. From this perspective, we must consider
how, from conception, our unique genetic endowment organizes and guides
4. This section draws heavily from the following source: William B. Hurlbut,
Personal Statement to PRESIDENT'S COUNCIL ON BIOETHiCS, HUMAN CLONING AND
HUMAN DIGNITY: AN ETHICAL INQUIRY 267 (President's Council on Bioethics 2002),
http://www.bioethics.gov/reports/cloningreport/appendix.html#hurbut.
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the expression of our particular nature in its species and individual character.
With regard to fundamental organismal existence (and inviolable moral
standing), the act of fertilization is a leap from zero to everything. The
gametes, which are properly understood as instrumentalities, parts of the
bodies of the parents, are not, in themselves, potential life; they are potential
causes of conception. The gametes themselves cease to be; they do not unite
in the sense of merely forming a larger composite, but bring into existence a
whole new entity, a new human life.
In both character and conduct, the zygote (the one cell embryo) and
subsequent embryonic stages differ from all other cells or tissues of the
body; they contain within themselves the organizing principle of the full
development of a human being. This is not an abstract or hypothetical
potential in the sense of mere possibility. Rather, it is a self-contained
"potency," an engaged and effective potential-in-process, an activated
dynamic of development in the direction of human fullness of being.
Unlike an assembly of parts in which a manufactured product is in no
sense "present" until there is a completed construction, a living being has a
continuous unfolding existence that is inseparable from its emerging form.
The form is, itself, a dynamic process rather than a static structure. In
biology, the whole (as the unified organismal principle of growth) precedes
and produces the parts. It is this implicit whole, with its inherent potency,
that endows the embryo with its human character and therefore, from this
perspective, its inviolable moral status. To interfere in its development is to
transgress upon a life in process. The principle of this analysis will apply to
any entity that has the same potency of a human embryo produced by natural
fertilization, regardless of whether it is the product of IVF, cloning, or other
processes.
ACCRUED MORAL STATUS
The major alternative to the view that an embryo has an inherent moral
status is the assertion that moral status is an accrued or accumulated quality
related to some physical dimension of form or function. Several arguments
have been put forward for this position.
Gastrulation
One such accrual argument is based on the assumption that before
gastrulation (which begins with the formation of the primitive streak around
the fourteenth day), the embryo is an inchoate clump of cells with no
actuated drive in the direction of distinct development. It is argued that the
undifferentiated quality of the blastocyst (the 4-5 day embryo) justifies its
disaggregation for the procurement of stem cells, while the evident
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organization at gastrulation reveals an organismal integrity that endows
inviolable moral status to all subsequent stages of embryological
development.
Scientific evidence, however, supports the opposing argument, i.e., that
from conception there is an unbroken continuity in the differentiation and
organization of the emerging individual life. The anterior-posterior axis
appears to be already established within the zygote; the first cell divisions
are asymmetric and early differences in gene expression suggest distinct cell
fates; and an overall pattern of integrated unity seems to indicate a
coherence of coordinated growth from the beginning.
All this implies that the changes at gastrulation do not represent a
discontinuity of ontological significance (a change in the nature of being)
but merely the visibly evident culmination of more subtle developmental
processes at the cellular level that are driving in the direction of organismal
maturity.5
Twinning
Another argument for accrued moral status is that, as long as an embryo is
capable of giving rise to a twin, it cannot be considered to have the moral
standing of an individual. Yet monozygotic twinning, which occurs in just
one in 240 births, does not appear to be either an intrinsic drive or a random
process within embryogenesis. Rather, it results from a disruption of normal
development by a mechanical or biochemical disturbance of fragile cell
relationships. This provokes a compensatory repair, but with the restitution
of integrity within two distinct trajectories of embryological development. 6
In considering the implications of twinning for individuation, one might
better ask the question from the opposite perspective. What keeps each of
the cells of the early embryo from becoming a full embryo? Clearly, crucial
relational dynamics of position and intercellular communication are already
at work establishing the unified pattern of the emerging individual.7 From
5. R. L. Gardner, Specification of Embryonic Axes Begins Before Cleavage in
Normal Mouse Development, DEVELOPMENT, 2001, at 839-47.; L. Grabel et al., Using
EC and ES Cell Culture to Study Early Development: Recent Observations on Indian
Hedgehog and BMPs, 42 INT'L J. DEVELOPMENTAL BIOLOGY 917, 917-25 (1998); K.
Piotrowska & M. Zemicka-Goetz, Role of Sperm in Spatial Patterning of the Early
Mouse Embryo, NATURE, 2001, at 517-21.
6. A.L.E.da Costa et al., Monozygotic Twins and Transfer at the Blastocyst Stage
After JCS1, 16 HUMAN REPRODUCTION 333, 333-36 (2001).
7. Q.T. Wang et al., A Genome- Wide Study of Gene Activity Reveals Developmental
Signaling Pathways in the Preimplantation Mouse Embryo, 6 DEVELOPMENTAL CELL
133, 133-44 (2001).
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this perspective, twinning is not evidence of the absence of an individual,
but of an extraordinary power of compensatory repair that reflects more fully
the potency of the individual drive to fullness of form, even in the earliest
stages of embryonic human life.
Implantation
Some have argued that the implantation of the embryo within the uterine
lining of the mother constitutes a moment of altered moral status.
Implantation, however, is actually a process that extends from around the
sixth or seventh day to about the eleventh or twelfth day, when the utero-
placental circulation is established. The more complex circulatory exchange
of the placenta simply extends the earlier relationship between mother and
embryo, in which diffusion of essential nutrients and growth factors sustain
the life and nourish the growth of the developing embryo. Implantation,
then, must be viewed as just another step in a continuum of ongoing intimate
dependence, all occurring along the trajectory of natural development that
begins with conception and continues into infancy. This continuity implies
no meaningful moral marker at implantation.
Some argue in the case of IVF, however, that before implantation the
embryo has no future prospects of development and therefore no natural
potential on which to base moral valuation. They speak of the "unenabled"
character of these entities, and claim this deficiency of context justifies their
use in scientific research. However, depriving an embryo of its environment
does not change its intrinsic nature. To deny the moral standing of the pre-
implantation embryo shifts the moral basis away from its intrinsic nature and
places it entirely within the realm of external intention, subject to the whim
of the research scientist.
Function
Most other arguments relate in some way to the onset of a specific
function or capacity. The first and most obvious problem is that the
essential functions (and even their minimal criteria and age of onset) are
diverse and arbitrarily assigned. Generally, they relate to the onset of
sentience, awareness of pain, or some apparently unique human cognitive
capability such as reflective self-consciousness.
This approach raises a number of disturbing ethical questions. If human
moral worth is based on actual manifest functions, then does more of that
function give an individual life a higher moral value? And what are we to
make of the parallel functional capacities in animals that we routinely
sacrifice for food and medical research? Furthermore, what becomes of
human moral status with the degeneration or disappearance of such
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functions? While we might argue that our relational obligations change
along with changes in function, such as occur with senile dementia, our
society would not sanction a utilitarian calculus and the purely instrumental
use of such persons, no matter how promising the medical benefits might be.
More fundamentally, from a scientific perspective, there is no meaningful
moment when one can definitively designate the biological origins of a
human characteristic such as consciousness. The human being is an
inseparable psycho-physical unity. Our thinking is in and through our
bodily being, and thus the roots of our consciousness reach deep into our
development. The earliest stages of human development serve as the
indispensable and enduring foundations for the powers of freedom and self-
awareness that reach their fullest expression in the adult form.
From the perspective of this analysis we can conclude that the embryo has
a moral status that is inherent and not an accrued or accumulated quality,
and that moral status must begin with the zygote (or clonote, as some call the
one cell product of nuclear transfer). Because it is intrinsic, such moral
status, as distinguished from developing relational obligations, is therefore
independent of: (a) the means by which the entity came into being (sexual
intercourse, IVF, cloning or other); (b) the present location of the entity (in
or outside of a natural or artificial womb); and (c) the intention according to
which such entity was produced (human reproduction, scientific and medical
research, medical therapeutic use, or other).
Failures of Fertilization
While inviolable moral standing is attributed to the human embryo, not
every combination of sperm and egg initiates a life; recent scientific
evidence suggests that many, perhaps most, early natural initiations in
reproduction result in 'failures of fertilization.' If the zygote lacks essential
elements, such as the necessary complement of chromosomes, epigenetic
configuration and cytoplasmic factors for gene expression, it will also lack
an inherent potency, a self-organizing drive in the direction of the mature
form. It will not have the characteristics necessary for it to be an organism,
and therefore will not be rightly considered a human embryo. Naturally
occurring failures of fertilization may still proceed along partial trajectories
of organic growth, however. For example, some gross abnormalities in the
combination or configuration of chromosomes will form a blastocyst but
will not exhibit the ordered growth and capacity for implantation that
characterize a natural embryo. Even an egg without a nucleus, when
artificially activated, has the developmental power to proceed through
8. A. Boue et al., Cytogenetics of Pregnancy Wastage, 4 ADVANCED HUM.
GENETICS 1, 1-57 (1985).
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several cell divisions, yet clearly it is not an embryo---or an organism at all.
Like a spinning top, the cells contain the molecular elements for a certain
biological momentum that propels a partial trajectory of development, but
unlike a normal embryo, they are unable to bootstrap themselves into
becoming an integrated and self-regulating organism.
Some of these aberrant products of fertilization that lack the qualities and
characteristics of an organism, appear to be capable of generating embryonic
stem cells or their functional equivalent. 9 Mature teratomas are tumors
(generally benign) that generate all three primary embryonic cell types as
well as more advanced cells and tissues, including partial limb and organ
primordia-and sometimes hair, fingernails and even fully formed teeth.
Yet these chaotic, disorganized, and nonfunctional masses are like a bag of
jumbled puzzle parts, lacking entirely the structural and dynamic character
of organisms. Neither medical science nor the major religious traditions
have ever considered these growths to be 'moral beings' worthy of
protection, even though they appear to produce embryonic stem cells.
SYSTEMS BIOLOGY
This example of disorganized growth provides a window into an
important new conceptual realm in the study of life. Through systems
biology, we are beginning to recognize how even a small change of one or a
few genes can affect the entire downstream working of an enormous
network of biochemical processes. Systems biology offers us the view of an
organism as a living whole, a dynamic network that is more than the sum of
its parts.
The very word organism implies organization, an overarching principle of
unity, a cooperative interaction of interdependent parts subordinated to the
good of the whole. As a living being, an organism is an integrated, self-
developing and self-maintaining unit under the governance of an immanent
plan. The philosopher Robert Joyce explains: "Living beings come into
existence all at once and then gradually unfold to themselves and to the
world what they already but only incipiently are." Joyce continues: "No
living being can become anything other than what it already essentially is."
l
For an embryonic organism, this implies an inherent potency, an activated
drive toward the mature human form. By its very nature, an embryo is a
developing being, its wholeness is defined by both its manifest expression
9. J.A. Byrne et al., From Intestine to Muscle: Nuclear Reprogramming through
Defective Cloned Embryos, 99 PROCEEDINGS OF THE NAT'L ACAD. Sci. 6059, 6059-6063
(2002).
10. Robert E. Joyce, Personhood and the Conception Event, 52 NEW SCHOLASTICISM
97, 97-109 (1978).
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and its latent potential; it is the phase of human life in which the organismal
whole produces its organic parts.
Such a conception of the biological organism transcends the "nothing but
its parts" perspective of reductionism. It adds the understanding that a living
being is not merely a mechanism, but rather, a dynamic system, an
interactive web of interdependent processes that expresses emergent
properties not apparent in the biochemical parts. 1 Within this dynamic self-
sustaining system is the very principle of life, the organizing information
and coordinating coherence of a living being. It is this over-arching harmony
of the whole, its internal balance, that distinguishes an organism from the
mere physio-chemical material of its parts. This inherent principle of organic
unity, in turn, provides the physical identity and continuity (and therefore the
moral continuity) of a human being from conception to natural death.
The new perspective of systems biology forms the intellectual grounding
for appreciating the physical and moral difference between an embryo and
an entity such as a teratoma. A teratoma is an inadequately constituted
biochemical system, a partial trajectory of development with an inherent
potential for only incomplete and unorganized growth. With the full
complement of coordinated parts, an organismal system subsumes and
sustains the parts; it exerts a downward causation that binds and balances the
parts into a patterned program of integrated growth and development.
Incompletely constituted or separated from the whole, the parts, as
subsystems of growth (cells, tissues and organs), may temporarily proceed
forward in partial development, but, without the self-regulating powers of
the organismal system, they will ultimately become merely disorganized
cellular growth. This distinction could provide the principle for the
resolution of our current controversy over ESC research. Altered Nuclear
Transfer (ANT) proposes that small but precisely selected alterations will
allow the harnessing of partial developmental trajectories, subsystems of
growth, apart from their full natural context in order to produce ES cells.
ALTERED NUCLEAR TRANSFER
As discussed above, natural conception signals the activation of the
organizing principle for the self-development and self-maintenance of the
full human organism. In the language of stem cell biology, this capability is
termed "totipotency," the capacity to form the complete organism. A
naturally fertilized egg, the one cell embryo, is totipotent. In contrast, the
term "pluripotency," designates the capacity to produce all the cell types of
11. The Greek root of our word organ means tool: an organism is an organic unity
whose parts subserve the whole.
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the human body but not the coherent and integrated unity of a living being.
ESCs are merely pluripotent. This is a difference between the material parts
and the living whole.
In standard nuclear transfer, the cell nucleus is removed from a somatic
cell and transferred into an oocyte that first has had its own nucleus
removed. Following the transfer, the oocyte has a full complement of DNA
and, after it is electrically stimulated, starts to divide like a naturally
fertilized egg. This is how Dolly the sheep was produced. ANT uses the
technology of nuclear transfer, but with a preemptive alteration that assures
that no embryo is created. The somatic cell nucleus or the enucleated egg's
contents (or both) are altered before the somatic cell nucleus is transferred
into the egg. The alterations cause the somatic cell DNA to function in such
a way that no embryo is generated, but pluripotent stem cells are
produced. 12 The laboratory construct that is produced by ANT has only
partial developmental potential. It lacks the integrated unity that
characterizes a human embryo, so the above ethical analysis would permit
harvesting its ESCs.
ANT is a broad concept with a range of possible approaches; there may be
many ways this technique can be used to accomplish the same end. As
described in a January 2006 paper in Nature magazine, stem cell biologist
Rudolf Jaenisch has established the scientific feasibility of one method of
ANT. In a series of dramatic mouse model studies, he procured fully
functional ESCs from a construct that is radically different in developmental
potential than a natural embryo.' 3 Using the technique of RNA interference,
he was able to reversibly silence the gene Cdx2 in the donor nucleus before
nuclear transfer to the enucleated egg. And a study just one month later in
the journal Science suggests that it may be possible to achieve the goals of
ANT through the preemptive silencing of Cdx2 in the egg even before the
act of nuclear transfer, thereby producing the biological (and moral)
equivalent of a single lineage tissue culture.' 4 This article showed that in
mice, messenger RNA for Cdx2 is present in the egg and asymmetrically
distributed in the first cell division after fertilization. This asymmetric
distribution of Cdx2 messenger RNA directs the cells at the two-cell stage to
form two distinct cell lineages. One of the cells at the two-cell stage goes on
12. Hearing on An Alternative Method for Obtaining Embryonic Stem Cells,
Subcomm. of Labor, Health and Human Services, Education of the S. Comm. on
Appropriations, 108th Cong. (Oct. 19, 2005) (testimony of Rudolf Jaenisch, M.D.).
13. A. Meissner & R. Jaenisch, Generation of Nuclear Transfer-Derived Pluripotent
ES Cells from Cloned Cdx2-Deficient Blastocysts, NATURE, Jan. 12, 2006, available at
http://www.nature.com/nature/journal/v439/n7073/abs/natureO425 7.html.
14. K. Deb et al., Cdx2 Gene Expression and Trophectoderm Lineage Specification
in Mouse Embryos 311 Sci. 992, 992-96 (2006).
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to become the trophectoderm and forms the outer layer of the embryo (and
later the extra-embryonic membranes, including the placenta). The other
cell forms the 'inner cell mass,' which is the source of embryonic stem cells.
By selective silencing of Cdx2, the authors were able to produce an
unorganized mass composed exclusively of cells with the character of inner
cell mass.
Unfortunately, the news reports describing the laboratory construct
produced by ANT have emphasized the inability to form the placenta. The
preemptive alteration of ANT, however, results in a failure of formation that
is earlier and far more fundamental than a mere inability to implant in the
womb. Due to the alteration, the first division into different cell lineages
does not occur, the body axes (top/bottom, front/back) cannot form, and the
basic human body plan is never established. There is no evidence of
unifying organization and no capacity to from a functional blastocyst, the
first structure with a clear distinction of parts. At this stage, such a critical
'deficiency' is more rightly considered an 'insufficiency,' not a defect in a
being, but an inadequacy at such a fundamental level that it precludes the
coordinated coherence and developmental potential that are the defining
characteristics of an embryonic organism.
ANT-OAR
Another variation of ANT called Oocyte Assisted Reprogramming (ANT-
OAR) has been put forward by Markus Grompe, Director of the Stem Cell
Center at Oregon Health Science University. In this variation of ANT,
alterations of the nucleus of the adult body cell and the enucleated egg's
contents before nuclear transfer would force early expression of genes
characteristic of a later and more specialized cell type that is capable of
producing pluripotent stem cells. Scientific evidence suggests that this
technique could be combined with the direct alteration of Cdx2 described
above to provide a complementary approach with increased scientific and
moral certitude. Such a creation, from its very beginning, would never have
the actual configuration or potential for development that characterizes a
human embryo. As documented on the Ethics and Public Policy Center
website this proposal has drawn wide endorsement from leading scientists,
moral philosophers and religious authorities.
15
15. Joint Statement, Ethics and Public Policy Center, Production of Pluripotent Stem
Cells by Oocyte Assisted Reprogramming (June 20, 2005), available at
http://www.eppc.org/publications/publD.23 74/pub detail.asp.
Altered Nuclear Transfer
The Preemptive Nature of ANT
The crucial principle of any technical variation of ANT, however, must be
the preemptive nature of the intervention. This process does not involve the
creation of an embryo that is then altered to transform it into a non-
embryonic entity. Rather, the proposed genetic alteration is accomplished
ab initio: the laboratory construct is brought into its very existence with a
genetic structure insufficient to generate a human embryo. From the
beginning, and at every point along its development, it cannot be designated
a living being. If such a limited biological construct were accorded a certain
cautionary respect-as with all human tissues-this project would not
compromise any fundamental moral principles. Moreover, such techniques
could be developed using animal models and confidently extended to work
with human cells without engaging in research that involves the destruction
of human embryos.
The Advantages of ANT
ANT would provide a uniquely flexible tool for embryonic stem cell
research. Embryos left over from IVF procedures represent a limited pool of
genotypes, all (presumably) from infertile couples. Furthermore, the
genomes of these embryos have never proven their capacity to form an
organism and, due to mutations, recombinations and reassortment of alleles
in gametogenesis, may carry unrecognized genetic defects. Embryonic stem
cells produced by ANT, however, would have genotypes of proven potential
from an adult donor. Furthermore, ANT could provide a full range of
genotypes, including patient-specific genetic types for tissue-compatible
transplantation. In addition, this technique would offer a far wider range of
scientific and medical possibilities than embryonic stem cell lines derived
from "left over" IVF embryos, including generation of diverse and pre-
designed stem cell lineages for disease modeling and pharmaceutical
development. Indeed, in allowing controlled and reproducible experiments,
ANT might serve as a temporary bridge to technologies such as direct
nuclear reprogramming. Furthermore, in establishing a morally acceptable
means for the procurement of ESCs, this important realm of scientific
investigation would be opened to federal funding and the advantages of both
broad public support and cooperative research collaboration on a national
level.
ANT would also unburden ESC research from the additional ethical
concerns of the "left over" IVF embryos, including the attendant clinical and
legal complexities in a realm of great personal and social sensitivity. The
one remaining link with IVF, the procurement of oocytes, is a subject of
intense scientific research and there appear to be several prospects for
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obtaining eggs without the morally dubious and expensive super-ovulation
of female patients.
CONCLUSION
As we enter the era of developmental biology, there will be many moral
dilemmas; the current conflict over ESCs is just the first in a series of
difficult controversies over the experimental use of emerging life that will
require that we define with clarity and precision the boundaries we seek to
defend. Similar concerns were raised over the past century as we came to
understand that human parts such as cells, tissues, and organs are not
themselves alive in a moral sense. Now, as we deepen our scientific inquiry
into human development, we may once again find a way forward by
studying parts apart from their place within the living whole. This will be a
more difficult challenge, however, both technically and conceptually; our
natural intuitions identify the dynamics of developing systems with the
moral meaning of living beings.
With the exploration of Altered Nuclear Transfer we open a realm of
intellectual dialogue and creative scientific investigation in the search for a
solution to our current impasse over the procurement of embryonic stem
cells. Such a solution must be grounded in deep ethical reflection and
careful preliminary studies with animal cells. The incommensurate good of
human life, and the corresponding danger of its instrumental use, means that
the highest levels of caution must prevail as we proceed forward with this
project. We must initiate the cooperative dialogue that is essential to frame
the moral principles that can at once defend human dignity and promote the
fullest prospects for scientific progress and its medical applications. The
constructive engagement of science and moral philosophy is a crucial
component of this dialogue-the very preservation of our humanity may
depend on it.
CODA
In May 2005, less than two weeks after publication of the White Paper on
"alternative sources" by the President's Council on Bioethics, the House
approved legislation (H.R.810) that would override President Bush's
executive order and allow federal funding of new stem cell lines created
from IVF embryos. In the succeeding months there was increasing media
attention to the quest for a technological resolution to our nation's impasse
over embryonic stem cell research. The expected mid-summer vote in the
Senate on H.R 810 was postponed due to an inability to establish a
'unanimous consent' agreement. Without such an agreement the House bill
would have been subject to amendment and forced into committee to
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reconcile the House and Senate version, or possibly even into filibuster. Just
before the summer recess, however, Senate Majority Leader William Frist
announced a change in his political position to one of support for the
pending legislation, and promised to bring the bill to the floor in a timely
manner.
Over the succeeding twelve months the politics of embryonic stem cell
research grew increasingly bitter. Finally, in July 2006, a unanimous
consent agreement was reached by packaging the House bill (H.R.810) with
two other bills, including one (S.2754) to mandate federal support for
projects such as ANT seeking 'alternative sources' of pluripotent stem cells.
This legislation was co-sponsored by Pennsylvania Senators Rick Santorum
and Arlen Specter, two politicians with opposing views on moral matters
related to stem cell research, and represented a rare but hopeful movement
toward common ground that could allow forward progress within social
consensus. Meanwhile the President reaffirmed the principle of his August
9, 2001 executive order, and promised to veto any legislation that would
seek to overturn his prior ruling.
On July 18, 2006, the Senate voted 63-37 for passage of H.R. 810, but this
left the bill short of the 2/3 needed to override a presidential veto. On the
same day, the "alternative sources" bill passed in the Senate by a vote of
100-0. This legislation was then sent immediately to the House with the
hope of delivering both bills to the President at the same time. This
scenario, however, was not to be. The proponent of H.R.810, in an apparent
effort to deprive the President of any pro-stem cell legislation to
counterbalance his veto, managed to muster enough votes to prevent the 2/3
needed under the procedural rules necessary for passage of the legislation
without amendment.
The following day, in a formal statement in the East Room of the White
House, the President cited the long-standing legislative tradition on which
his policy is built and strongly reaffirmed his administration's position on
research that involves the destruction of human embryos. Surrounded by
young couples holding "snowflake" babies, born though embryo adoption,
he said, "These boys and girls are not spare parts. They remind us of what is
lost when embryos are destroyed in the name of research." And,
reproaching Congress for failing to pass the 'alternative sources' legislation,
he announced his intention to issue a Presidential Directive to promote this
"vital and ethical" approach toward a resolution of our nation's difficult
impasse over embryonic stem cell research.
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